Protara Therapeutics Stock Price on May 24, 2024
| TARA Stock | USD 6.19 0.06 0.96% |
Below is the normalized historical share price chart for Protara Therapeutics extending back to October 22, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protara Therapeutics stands at 6.19, as last reported on the 12th of December 2024, with the highest price reaching 6.19 and the lowest price hitting 6.19 during the day.
If you're considering investing in Protara Stock, it is important to understand the factors that can impact its price. Protara Therapeutics is relatively risky given 3 months investment horizon. Protara Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.22, which implies the firm had a 0.22% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 2.35% are justified by taking the suggested risk. Use Protara Therapeutics Coefficient Of Variation of 435.0, semi deviation of 3.37, and Risk Adjusted Performance of 0.1754 to evaluate company specific risk that cannot be diversified away.
At present, Protara Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 12.9 K, whereas Other Stockholder Equity is forecasted to decline to about 237.6 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 8.65. Protara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of October 2014 | 200 Day MA 2.6874 | 50 Day MA 2.5904 | Beta 1.786 |
Protara |
Sharpe Ratio = 0.2231
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | TARA | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.54 actual daily | 93 93% of assets are less volatile |
Expected Return
| 2.35 actual daily | 46 54% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Protara Therapeutics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protara Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.5764 | Book Value 6.012 | Enterprise Value 52.2 M | Enterprise Value Ebitda 0.7403 | Shares Float 15.2 M |
Related Headline
Zentalis Pharmaceuticals Headline on 24th of May 2024
Insider Trading by Walker Luke Nathaniel Filed transaction by Zentalis Pharmaceuticals Llc Director: . Insider Public Trading |
Protara Therapeutics Valuation on May 24, 2024
It is possible to determine the worth of Protara Therapeutics on a given historical date. On May 24, 2024 Protara was worth 2.77 at the beginning of the trading date compared to the closed value of 2.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Protara Therapeutics stock. Still, in general, we apply an absolute valuation method to find Protara Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Protara Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Protara Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.98 | 3.03 | 2.74 | 2.76 | 393,561 | |
05/24/2024 | 2.77 | 2.87 | 2.68 | 2.80 | 222,179 |
| 2.81 | 2.88 | 2.68 | 2.79 | 209,649 |
| Backtest Protara Therapeutics | | | Protara Therapeutics History | | | Protara Therapeutics Valuation | Previous | Next |
Protara Therapeutics Trading Date Momentum on May 24, 2024
| On May 28 2024 Protara Therapeutics was traded for 2.79 at the closing time. The top price for the day was 2.88 and the lowest listed price was 2.68 . The trading volume for the day was 209.6 K. The trading history from May 28, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.36% . The trading delta at closing time against the current closing price is 0.36% . |
Protara Therapeutics Fundamentals Correlations and Trends
By evaluating Protara Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Protara Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Protara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Protara Therapeutics Stock history
Protara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protara Therapeutics stock prices may prove useful in developing a viable investing in Protara Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11.3 M | 11.9 M | |
| Net Loss | -59.4 M | -56.4 M |
Protara Therapeutics Quarterly Net Working Capital |
|
Protara Therapeutics Stock Technical Analysis
Protara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Protara Therapeutics Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Protara Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Protara Therapeutics December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Protara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protara Therapeutics shares will generate the highest return on investment. By undertsting and applying Protara Therapeutics stock market strength indicators, traders can identify Protara Therapeutics entry and exit signals to maximize returns
Protara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1754 | |||
| Jensen Alpha | 2.5 | |||
| Total Risk Alpha | 0.728 | |||
| Sortino Ratio | 0.5062 | |||
| Treynor Ratio | (1.99) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |